PARTICIPATING ORGANISATIONS - 2023
The Cambridge Science Park was established 52 years ago when Trinity College Cambridge embraced the concept that would change the hi-tech sector in Cambridge, the UK and beyond. Trinity owns the freehold of the Cambridge Science Park, which today comprises 150 acres, 1.7 million sq ft of high technology and laboratory buildings. It’s home to 7000 people at over 130 companies, ranging from exciting start-ups to some of the world's leading technology businesses.
Founded in 1987, we are a sector-agnostic home for some 80 innovative companies: scaling-up, going international and raising risk capital. The Centre is set in extensive grounds within easy access of central Cambridge and has a popular restaurant and conference suite.
At Illumina, our mission is to improve human health by unlocking the power of the genome. By delivering breakthroughs that redefine what's possible in genomics, we empower visionaries around the globe to uncover answers and make life-changing advances.
ET Capital Limited, founded in 1992, is an investor in high-growth technology businesses based in southern England. The firm has raised and managed a series of funds focused on the globally significant cluster of science-based businesses around Cambridge, Oxford and London. Its first two funds, now closed, were backed by HSBC and the European Investment Fund.
Carbon-13 (13C) is a natural, stable isotope of carbon with a nucleus containing six protons and seven neutrons. They are the venture builder for the climate emergency, with a mission to reduce CO2e emissions by 400m tonnes through scalable climate tech ventures
Ethicronics main activity is hardware-enabled cybersecurity fighting against counterfeit and compromised electronics. Their first unique selling point is certifying your hardware is the one designed, at scale. Their SaaS solution provides hardware integrity certificates for market segments such as defence, security, transport, communication, finance and IoT.
Innovate UK is the UK’s national innovation agency. They support business-led innovation in all sectors, technologies and UK regions. It help businesses grow through the development and commercialisation of new products, processes, and services, supported by an outstanding innovation ecosystem that is agile, inclusive, and easy to navigate.
Neurolentech was founded in late 2020 as a spin-out from IST Austria to identify new treatments for neurodevelopmental disorders. They use the latest scientific laboratory techniques to develop patient-derived neuronal cell models that give us insights into the molecular mechanisms of disease.
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
AI VIVO is a Cambridge (UK) based company with a unique systems pharmacology platform powered by AI to accelerate drug discovery. They are developing a new generation of multi-diciplinary team including biologists, ML/AI experts, drug designers & development scientists guided by an advisory board including serial entrepreneurs and pharma executives with decades experience in building and scaling successful enterprises.
Building on over 200 years of heritage, we are a major UK law firm located in the heart of Cambridge and six other cities across the country. Our office at Botanic House on Hills Road will be hosting 10 science and tech companies who will be waiting to meet and chat with you about their work.
CMR Surgical is a British medical device company based in Cambridge. It produces a Robot-assisted surgery system called Versius. With Versius, their goal is to empower surgeons to transform how surgery is performed across the world.
Lives can be transformed when the strength of academia and business combine. As a biomedical institute, the Milner Therapeutics Institute acts as a catalyst and a driver, forming dynamic partnerships to unlock the power of emerging discoveries.
The Milner encompasses both a research institute and a global outreach programme, which aims to transform pioneering science into therapies. The Institute is also home to the Frame Shift Bio-incubator, which provides space for start-ups and SMEs.
Babraham Research Campus Ltd is responsible for the development and management of the Campus on behalf of its shareholders; BBSRC-UKRI and the Babraham Institute. The Campus is one of the UK’s leading places to support early-stage bioscience enterprise.
Form the Future CIC connects young people to a world of career possibilities, inspires them to dream big and empowers them to fulfil their full potential.
Deep Mirror is a team of leading experts at the interface of biology, physics, and machine learning, we are committed to bold innovation and on a clear mission: to elevate learning in the Life Sciences and power innovation in the century of biology.
Exonate is a biopharmaceutical company focused on the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need.
The Henry Royce Institute, known as Royce, is the UK's national institute for advanced materials science research and innovation.
Royce@Cambridge is one of Royce’s nine partners, funded by the Engineering & Physical Sciences Research Council (EPSRC), which is part of UK Research & Innovation (UKRI).
Five Alarm Bio is a drug discovery company based in Cambridge, UK focusing on novel approaches to
anti-aging, with broad potential therapeutic application.
Kuano is focused on the discovery of new drugs with a novel AI and quantum simulation approach to finding better transition state-like inhibitors to overcome resistance by mutation. Kuano revolutionized this approach, once time-consuming and expensive, making it more rapid, cost-effective, and applicable to almost every therapeutic field.
CorrosionRADAR is a revolutionary patented sensing technology enabling the early detection, monitoring and prediction of hidden corrosion such as Corrosion Under Insulation (CUI). Their advanced and patented systems can identify, localise and monitor the presence of corrosion and moisture under any type of insulation or any type of asset.
Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential. Our team is comprised of experienced investors and entrepreneurs. In addition to capital, we can offer support, experience and a network of contacts.
Informetis creates value out of energy data. Their four technology pillars: Metis Device, Metis Cloud, Metis Engine and Metis App. Creating value out of energy data by utilising these unique tools, we call it Energy Informetis.
Based on the Cambridge Science Park, Qkine combines proprietary protein production processes developed at the University of Cambridge with protein engineering techniques to develop unique products that tackle fundamental biological and scale-up challenges for the fast-growing stem cell, organoid, regenerative medicine and cellular agriculture sectors.
Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised, allowing our customers to understand the machinery of life.
Penningtons Manches Cooper is a leading UK and international law firm which provides high quality legal advice tailored to both businesses and individuals. We address the specific objectives of each client through our flair and technical expertise and offer a personal service founded on a strong team ethic.
BioBeat connects entrepreneurs with biotech leaders. The annual summit challenges current thinking and the report selects 50 women trend setters.
CK Group is a leading specialist recruitment company with a global reach. They have grown to become a dominant force in scientific, clinical, and technical recruitment, and have a long history of working with fantastic companies and talented people.
At the Wellcome Genome Campus we undertake genome and biodata research. We provide bioinformatics services to the world and we deliver vital training in genomics and biodata to scientists and clinicians. We are at the interface of research and industry translating science into tangible societal benefits.
Nuclera: Rapid protein prototyping — it’s what we do. It’s what we deliver. Rapid protein prototyping draws a straight line from theory to reality, allowing scientists to test hypotheses more efficiently. We understand that scientists need access to protein prototyping on their own bench, on their own terms.
VetCT provides vet-to-specialist teleconsulting and teleradiology services, and novel educational strategies for veterinary medicine. Our mission is to make the veterinary world a better place by delivering trusted veterinary knowledge, support and reassurance at the point of need.
Unity Campus is an exciting new urban innovation district in the heart of the Cambridgeshire countryside. Campus owners Howard Group, a Cambridge-based family business with a 50-year track record as a long-term property investor and developer, is transforming the site of a former tannery into a stunning modern workplace.
PhoreMost has developed a next-generation phenotypic screening platform called SITESEEKER® which can discern the best new targets for future therapies and, crucially, how to drug them. This has the potential to significantly increase the diversity of novel therapeutics for cancers and other disease of unmet need.
NanoVation Therapeutics (NTx) is an early-stage gene therapy company developing next-generation platform technologies utilizing lipid nanoparticles for the safe and efficient delivery of nucleic acids to a variety of tissues. Focused on translating personalized gene therapies to the clinic, NTx aims to treat and prevent multiple age-related diseases enabling a healthier tomorrow, TODAY.
We have Future Business Centres in Cambridge and Peterborough that offer flexible workspace, meeting rooms and networking, all within environmentally focused buildings – creating innovation communities for local businesses and social enterprises. Our expert programme team in East London work with local businesses to help them build resilience, grow and create positive impact.
Astex has built a rich product portfolio with multiple drugs in clinical development. Our research and development teams utilize our cutting edge technology platform in the relentless pursuit of innovative solutions that address the extensive and complex challenges in oncology and diseases of the CNS.
Enterprise is an area that clearly defines NatWest. As the UK’s biggest bank for business, we understand that SMEs are the lifeblood of the economy and that we have a responsibility to help them build back better. At the heart of our support for entrepreneurs is our comprehensive Accelerator programme including fully funded mentoring, insight and bespoke coaching, specifically designed to meet the needs of business owners who want to grow and scale their business, regardless of geographic location or sector.
The Cambridge Future Tech Venture Builder provides inventors, innovators and founders with the tools and collaboration required to succeed in building a DeepTech company.
Enhanc3DGenomics' mission is to unlock the full potential of the human genome’s 3D organisation for target and biomarker discovery. They have expertise in developing an unparalleled platform integrating proprietary molecular biology technologies with machine learning to maximise the commercial potential of 3D genomics.
Creasallis was founded in 2021 by Zahra Jawad. It was created after the realization that innovation is limited in the pharmaceutical industry as the product pipeline dominates in this environment, and competition for resourcing and facilities is high. To make truly innovative drugs, start ups are needed to create that safe space to explore novel solutions.
AA Thornton is a leading firm of Intellectual Property professionals, including UK Chartered and European Patent Attorneys and Trade Mark Attorneys and IP Solicitors based in London and Alicante.
TusPark Holdings UK is a science and technology service corporation with an investment arm as a venture capital and private equity group fund. TUS has invested £250M+ in science and technology sector in the UK since 2018 and its investment portfolio spans in the era of life science/healthcare, digital technologies (big data, AI and IoT, etc.), new material, and environmental & new energy, with a unique model of "Incubation + Investment + cross-border M&As".
Part of the University of Cambridge, Cambridge Enterprise is responsible for supporting the translation of University research to create globally leading economic and social impact. We facilitate knowledge transfer by helping innovators, experts, and entrepreneurs to use commercial avenues to develop their ideas and expertise for the benefit of society, the economy, themselves, and the University.
The Cambridge Judge Entrepreneurship Centre is where entrepreneurship gets real. It is where ground-breaking research and excellence in teaching combine to create global impact and enable entrepreneurs to turn ideas or innovations into real commercial applications and sustainable businesses. The Entrepreneurship Centre supports entrepreneurs and innovators at different stages from aspiration to venture creation and startup development, through to expansion and growth. We offer multiple entry points to resources, programmes and networks allowing individuals to structure and customise a personal journey directly relevant to them and their ventures.
Melbourn Science Park by Bruntwood SciTech offers world class office, laboratory and co-working space across the UK and is home to over 500 science and technology businesses. A 50:50 joint venture between Bruntwood and Legal & General, they create specialist working environments and provide support for businesses to start, scale and innovate. With science and technology ecosystems located in Manchester, Cheshire, Birmingham, Leeds, Liverpool and Glasgow, they acquired Melbourn Science Park, Cambridgeshire, in 2021. Plans have been submitted for a ten-year masterplan to redevelop the site into a globally recognised life science campus where research, innovation and manufacturing come together and change the future of human health. The Park will provide an inclusive place to work and socialise, promoting wellbeing and community for both local residents and businesses on the campus.
We founded Kalium Health with the aim of providing real-world electrolyte data to transform the management of cardiorenal diseases. We have a world-class team, led by science and dedicated to medical product development. Our clinical focus is on kidney disease, heart disease and related chronic conditions where the cost of care is disproportionately high and the opportunity to improve health outcomes for a large population is great.
HRS are a member of the Recruitment and Employment Confederation (REC) ensuring best practise with all currently employability legislation, and are also an accredited Investor In people for our outstanding commitment to sustainability in our workforce.
SMDG is developing safe, innovative and disease-modifying therapies for some of the most debilitating diseases our societies face today. SMDG's team has focused on neurodegenerative diseases and pediatric neurological disorders as the first diseases to tackle.
Springboard is a team of talented engineers and scientists that are driven by a passion for solving difficult technical challenges and developing successful products that help people around the world.
Our established group of experienced scientists is based at our fully-equipped research laboratories in Cambridge, UK. We integrate fragment-based approaches, structural biology, biophysics, assay technology and molecular modelling with extensive synthetic organic and medicinal chemistry expertise to enable drug discovery on both established and novel targets.
Carter Jonas was founded in 1855, when John Carter Jonas set himself up as an auctioneer in Cambridge.
Today, Carter Jonas has over 800 people working in 34 offices, strategically placed across the UK. Our corporate head office is located in Chapel Place near Oxford Street in Central London.
Since 2011, we’ve been connecting organisations of all shapes and sizes; fast becoming one of the industry’s leading internet service and managed security providers.
The Cambridge Crystallographic Data Centre (CCDC) are world-leading experts in structural chemistry data, software, and knowledge for materials and life sciences research and development.
CCDC data, software, and services are trusted by academic and industrial institutions around the world with tens of thousands of active users from top 10 pharma to leading research institutions.
Cambridge Network is a membership organisation bringing people together through networking, learning, recruitment and events. We connect and support businesses, sparking collaboration within our vibrant network of over a thousand members.
Start Codon is a venture capital investor and venture builder based in Cambridge, England. We support aspiring entrepreneurs to spin out and/or help in the development and commercialisation of their disruptive innovations. In doing so, we aim to help them craft their vision into thriving companies that improve people’s lives and address unmet needs.
o2h co-work labs operates the mill scitech park in Hauxton, Cambridge, a place for entrepreneurs, scientists, techies & dreamers. Supported by high specification labs to create a genuinely unique environment for creativity and innovation to thrive.